1. Home
  2. ASTE vs HROW Comparison

ASTE vs HROW Comparison

Compare ASTE & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASTE

Astec Industries Inc.

HOLD

Current Price

$55.80

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$43.53

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
HROW
Founded
1972
1998
Country
United States
United States
Employees
N/A
373
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
ASTE
HROW
Price
$55.80
$43.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$66.00
$69.86
AVG Volume (30 Days)
199.3K
836.2K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.85%
N/A
EPS Growth
784.21
N/A
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
$14.72
$31.62
Revenue Next Year
$5.44
$50.77
P/E Ratio
$918.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.83
$28.54
52 Week High
$65.69
$54.98

Technical Indicators

Market Signals
Indicator
ASTE
HROW
Relative Strength Index (RSI) 49.61 60.44
Support Level $55.74 $40.56
Resistance Level $63.89 $44.50
Average True Range (ATR) 2.28 2.13
MACD -0.39 0.18
Stochastic Oscillator 20.24 52.78

Price Performance

Historical Comparison
ASTE
HROW

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: